These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Potential public health impact of RTS,S malaria candidate vaccine in sub-Saharan Africa: a modelling study. Sauboin CJ; Van Bellinghen LA; Van De Velde N; Van Vlaenderen I Malar J; 2015 Dec; 14():524. PubMed ID: 26702637 [TBL] [Abstract][Full Text] [Related]
5. Malaria & mRNA Vaccines: A Possible Salvation from One of the Most Relevant Infectious Diseases of the Global South. Borkens Y Acta Parasitol; 2023 Dec; 68(4):916-928. PubMed ID: 37828249 [TBL] [Abstract][Full Text] [Related]
7. First malaria vaccine slashes childhood deaths. Wadman M Science; 2023 Oct; 382(6669):357. PubMed ID: 37883572 [TBL] [Abstract][Full Text] [Related]
8. Second malaria vaccine gets WHO green light. Vogel G Science; 2023 Oct; 382(6666):16-17. PubMed ID: 37797033 [TBL] [Abstract][Full Text] [Related]
9. Preventing malaria in endemic areas. Roberts DR BMJ; 2007 Nov; 335(7628):1001-2. PubMed ID: 17959734 [TBL] [Abstract][Full Text] [Related]
10. The paradox of endemic stability. Hay SI Trends Parasitol; 2001 Jul; 17(7):310. PubMed ID: 11423357 [No Abstract] [Full Text] [Related]
11. Systematic Review of Safety of RTS,S with AS01 and AS02 Adjuvant Systems Using Data from Randomized Controlled Trials in Infants, Children, and Adults. Yihunie W; Kebede B; Tegegne BA; Getachew M; Abebe D; Aschale Y; Belew H; Bahiru B Clin Pharmacol; 2023; 15():21-32. PubMed ID: 36941908 [TBL] [Abstract][Full Text] [Related]
13. Immune mechanisms in malaria: new insights in vaccine development. Riley EM; Stewart VA Nat Med; 2013 Feb; 19(2):168-78. PubMed ID: 23389617 [TBL] [Abstract][Full Text] [Related]
14. Recent advances in the development of immunotherapies for tauopathies. Ubhi K; Masliah E Exp Neurol; 2011 Aug; 230(2):157-61. PubMed ID: 20970422 [TBL] [Abstract][Full Text] [Related]
15. Safety and immunogenicity of an investigational adjuvanted hepatitis B vaccine (HB-AS02V) in healthy adults. Beran J; Hobzova L; Wertzova V; Kuriyakose S; Leyssen M; Surquin M; Houard S Hum Vaccin; 2010 Jul; 6(7):578-84. PubMed ID: 20523113 [TBL] [Abstract][Full Text] [Related]
16. Sterile protection against Plasmodium knowlesi in rhesus monkeys from a malaria vaccine: comparison of heterologous prime boost strategies. Jiang G; Shi M; Conteh S; Richie N; Banania G; Geneshan H; Valencia A; Singh P; Aguiar J; Limbach K; Kamrud KI; Rayner J; Smith J; Bruder JT; King CR; Tsuboi T; Takeo S; Endo Y; Doolan DL; Richie TL; Weiss WR PLoS One; 2009 Aug; 4(8):e6559. PubMed ID: 19668343 [TBL] [Abstract][Full Text] [Related]
17. T-cell epitope polymorphisms of the Plasmodium falciparum circumsporozoite protein among field isolates from Sierra Leone: age-dependent haplotype distribution? Jalloh A; Jalloh M; Matsuoka H Malar J; 2009 Jun; 8():120. PubMed ID: 19500348 [TBL] [Abstract][Full Text] [Related]
18. Defined tuberculosis vaccine, Mtb72F/AS02A, evidence of protection in cynomolgus monkeys. Reed SG; Coler RN; Dalemans W; Tan EV; DeLa Cruz EC; Basaraba RJ; Orme IM; Skeiky YA; Alderson MR; Cowgill KD; Prieels JP; Abalos RM; Dubois MC; Cohen J; Mettens P; Lobet Y Proc Natl Acad Sci U S A; 2009 Feb; 106(7):2301-6. PubMed ID: 19188599 [TBL] [Abstract][Full Text] [Related]
19. RTS,S/AS02A for malaria. Bojang KA Expert Rev Vaccines; 2006 Oct; 5(5):611-5. PubMed ID: 17181435 [TBL] [Abstract][Full Text] [Related]